Aurobindo Pharma USA selects Durham for R&D manufacturing center and 275 jobs
DURHAM, N.C. — Supported by incentives under the North Carolina Job Development Investment Grant (JDIG) program plus Durham economic development incentives, Aurobindo Pharma USA is investing over $31.7 million in a new state-of-the-art national headquarters for specialty pharmaceutical R&D.
The company expects to create 275 new R&D and pharma-manufacturing jobs in Durham. The company currently employs 14 scientists and workers in Raleigh. Their expanded operations will create a $17.1 million annual payroll impact for Durham and surrounding counties. Check for Aurobindo Pharma USA jobs here.
Dayton, New Jersey-based Aurobindo Pharma USA is a unit of Aurobindo Pharma Limited, headquartered in Hyderabad, India. The publicly-held parent company (BSE: AUROPHARMA) is recognized as one of the top 10 pharmaceutical companies (brand or generic) in terms of total prescriptions dispensed.
Last year, Forbes Asia named Aurobindo Pharma to its “Fabulous 50” list. The company employs a worldwide workforce of 15,500.